260 related articles for article (PubMed ID: 33155341)
21. Neoantigens and the tumor microenvironment play important roles in the prognosis of high-grade serous ovarian cancer.
Yang H; Yu M; Zhong S; You Y; Feng F
J Ovarian Res; 2022 Jan; 15(1):18. PubMed ID: 35093146
[TBL] [Abstract][Full Text] [Related]
22. RVboost: RNA-seq variants prioritization using a boosting method.
Wang C; Davila JI; Baheti S; Bhagwate AV; Wang X; Kocher JP; Slager SL; Feldman AL; Novak AJ; Cerhan JR; Thompson EA; Asmann YW
Bioinformatics; 2014 Dec; 30(23):3414-6. PubMed ID: 25170027
[TBL] [Abstract][Full Text] [Related]
23. Neoantigens elicit T cell responses in breast cancer.
Morisaki T; Kubo M; Umebayashi M; Yew PY; Yoshimura S; Park JH; Kiyotani K; Kai M; Yamada M; Oda Y; Nakamura Y; Morisaki T; Nakamura M
Sci Rep; 2021 Jun; 11(1):13590. PubMed ID: 34193879
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
O'Donnell T; Christie EL; Ahuja A; Buros J; Aksoy BA; Bowtell DDL; Snyder A; Hammerbacher J
BMC Cancer; 2018 Jan; 18(1):87. PubMed ID: 29357823
[TBL] [Abstract][Full Text] [Related]
25. Transcriptomic-Assisted Immune and Neoantigen Profiling in Premalignancy.
Chang K; McAllister F; Vilar E
Methods Mol Biol; 2022; 2435():95-105. PubMed ID: 34993941
[TBL] [Abstract][Full Text] [Related]
26. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.
Snyder A; Nathanson T; Funt SA; Ahuja A; Buros Novik J; Hellmann MD; Chang E; Aksoy BA; Al-Ahmadie H; Yusko E; Vignali M; Benzeno S; Boyd M; Moran M; Iyer G; Robins HS; Mardis ER; Merghoub T; Hammerbacher J; Rosenberg JE; Bajorin DF
PLoS Med; 2017 May; 14(5):e1002309. PubMed ID: 28552987
[TBL] [Abstract][Full Text] [Related]
27. Reliable identification of genomic variants from RNA-seq data.
Piskol R; Ramaswami G; Li JB
Am J Hum Genet; 2013 Oct; 93(4):641-51. PubMed ID: 24075185
[TBL] [Abstract][Full Text] [Related]
28. Indel sensitive and comprehensive variant/mutation detection from RNA sequencing data for precision medicine.
Prodduturi N; Bhagwate A; Kocher JA; Sun Z
BMC Med Genomics; 2018 Sep; 11(Suppl 3):67. PubMed ID: 30255803
[TBL] [Abstract][Full Text] [Related]
29. Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.
Ha KC; Lalonde E; Li L; Cavallone L; Natrajan R; Lambros MB; Mitsopoulos C; Hakas J; Kozarewa I; Fenwick K; Lord CJ; Ashworth A; Vincent-Salomon A; Basik M; Reis-Filho JS; Majewski J; Foulkes WD
BMC Med Genomics; 2011 Oct; 4():75. PubMed ID: 22032724
[TBL] [Abstract][Full Text] [Related]
30. Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling.
Nguyen BQT; Tran TPD; Nguyen HT; Nguyen TN; Pham TMQ; Nguyen HTP; Tran DH; Nguyen V; Tran TS; Pham TN; Le MT; Phan MD; Giang H; Nguyen HN; Tran LS
Front Immunol; 2023; 14():1251603. PubMed ID: 37731488
[TBL] [Abstract][Full Text] [Related]
31. NeoFuse: predicting fusion neoantigens from RNA sequencing data.
Fotakis G; Rieder D; Haider M; Trajanoski Z; Finotello F
Bioinformatics; 2020 Apr; 36(7):2260-2261. PubMed ID: 31755900
[TBL] [Abstract][Full Text] [Related]
32. Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma.
Yang H; Sun L; Guan A; Yin H; Liu M; Mao X; Xu H; Zhao H; Lu X; Sang X; Zhong S; Chen Q; Mao Y
Cancer Immunol Immunother; 2021 Mar; 70(3):667-677. PubMed ID: 32876735
[TBL] [Abstract][Full Text] [Related]
33. CoDE-seq, an augmented whole-exome sequencing, enables the accurate detection of CNVs and mutations in Mendelian obesity and intellectual disability.
Montagne L; Derhourhi M; Piton A; Toussaint B; Durand E; Vaillant E; Thuillier D; Gaget S; De Graeve F; Rabearivelo I; Lansiaux A; Lenne B; Sukno S; Desailloud R; Cnop M; Nicolescu R; Cohen L; Zagury JF; Amouyal M; Weill J; Muller J; Sand O; Delobel B; Froguel P; Bonnefond A
Mol Metab; 2018 Jul; 13():1-9. PubMed ID: 29784605
[TBL] [Abstract][Full Text] [Related]
34. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.
Khater F; Vairy S; Langlois S; Dumoucel S; Sontag T; St-Onge P; Bittencourt H; Dal Soglio D; Champagne J; Duval M; Leclerc JM; Laverdiere C; Tran TH; Patey N; Ellezam B; Perreault S; Piché N; Samson Y; Teira P; Jabado N; Michon B; Brossard J; Marzouki M; Cellot S; Sinnett D
JAMA Netw Open; 2019 Apr; 2(4):e192906. PubMed ID: 31026031
[TBL] [Abstract][Full Text] [Related]
35. Indel detection from RNA-seq data: tool evaluation and strategies for accurate detection of actionable mutations.
Sun Z; Bhagwate A; Prodduturi N; Yang P; Kocher JA
Brief Bioinform; 2017 Nov; 18(6):973-983. PubMed ID: 27473065
[TBL] [Abstract][Full Text] [Related]
36. Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network.
Zeng Z; Fu J; Cibulskis C; Jhaveri A; Gumbs C; Das B; Sanchez-Espiridion B; Janssens S; Taing L; Wang J; Lindsay J; Vilimas T; Zhang J; Tokheim C; Sahu A; Jiang P; Yan C; Duose DY; Cerami E; Chen L; Cohen D; Chen Q; Enos R; Huang X; Lee JJ; Liu Y; Neuberg DS; Nguyen C; Patterson C; Sarkar S; Shukla S; Tang M; Tsuji J; Uduman M; Wang X; Weirather JL; Yu J; Yu J; Zhang J; Zhang J; Meerzaman D; Thurin M; Futreal A; Karlovich C; Gabriel SB; Wistuba II; Liu XS; Wu CJ
Clin Cancer Res; 2021 Sep; 27(18):5049-5061. PubMed ID: 33323402
[TBL] [Abstract][Full Text] [Related]
37. RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer.
Lang JE; Ring A; Porras T; Kaur P; Forte VA; Mineyev N; Tripathy D; Press MF; Campo D
Ann Surg Oncol; 2018 Aug; 25(8):2261-2270. PubMed ID: 29868978
[TBL] [Abstract][Full Text] [Related]
38. ScanNeo: identifying indel-derived neoantigens using RNA-Seq data.
Wang TY; Wang L; Alam SK; Hoeppner LH; Yang R
Bioinformatics; 2019 Oct; 35(20):4159-4161. PubMed ID: 30887025
[TBL] [Abstract][Full Text] [Related]
39. A novel neoantigen discovery approach based on chromatin high order conformation.
Shi Y; Zhang M; Meng L; Su X; Shang X; Guo Z; Li Q; Lin M; Zou X; Luo Q; Yu Y; Wu Y; Da L; Cai TW; He G; Han ZG
BMC Med Genomics; 2020 Aug; 13(Suppl 6):62. PubMed ID: 32854726
[TBL] [Abstract][Full Text] [Related]
40. Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.
Callari M; Batra AS; Batra RN; Sammut SJ; Greenwood W; Clifford H; Hercus C; Chin SF; Bruna A; Rueda OM; Caldas C
BMC Genomics; 2018 Jan; 19(1):19. PubMed ID: 29304755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
